214 related articles for article (PubMed ID: 6155233)
21. In vitro influence of endotoxin on human mononuclear phagocyte structure and function. 2. Enhancement of the expression of cytoststic and cytolytic activity of normal and lymphokine-activated monocytes.
Hammerstrøm J
Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):391-9. PubMed ID: 397718
[TBL] [Abstract][Full Text] [Related]
22. Interferon as a macrophage activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals.
Dean RT; Virelizier JL
Clin Exp Immunol; 1983 Mar; 51(3):501-10. PubMed ID: 6342884
[TBL] [Abstract][Full Text] [Related]
23. Natural cytotoxic activity in human lungs.
Bordignon C; Villa F; Vecchi A; Giavazzi R; Introna M; Avallone R; Mantovani A
Clin Exp Immunol; 1982 Feb; 47(2):437-44. PubMed ID: 6176378
[TBL] [Abstract][Full Text] [Related]
24. Macrophage antitumor activity in vitro. Comparative analysis of cytolytic, cytostatic, and cytotoxic activities of mouse macrophages and human monocytes.
Soldateschi D; Censini S; de Gori V; Antoni G; Tagliabue A; Boraschi D
Immunobiology; 1984 May; 166(3):251-62. PubMed ID: 6376332
[TBL] [Abstract][Full Text] [Related]
25. [Methodological variants in the optimal determination of the activity of natural killers and mononuclear phagocytes by analysis at the single-cell level].
Gordienko SM; Avdiunicheva OE
Eksp Onkol; 1985; 7(6):38-41. PubMed ID: 4085396
[TBL] [Abstract][Full Text] [Related]
26. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing.
Martin JH; Edwards SW
J Immunol; 1993 Apr; 150(8 Pt 1):3478-86. PubMed ID: 8385686
[TBL] [Abstract][Full Text] [Related]
27. Spontaneous and induced cytotoxic properties of human adherent mononuclear cells: killing of non-sensitized and antibody-coated non-erythroid cells.
Horwitz DA; Kight N; Temple A; Allison AC
Immunology; 1979 Feb; 36(2):221-8. PubMed ID: 220181
[TBL] [Abstract][Full Text] [Related]
28. Human peripheral blood monocyte and bronchoalveolar macrophage cytotoxicity for cultured human lung tumor cells.
Swinburne S; Cole P
J Reticuloendothel Soc; 1982 Nov; 32(5):371-85. PubMed ID: 6761437
[TBL] [Abstract][Full Text] [Related]
29. Chromium and tritiated thymidine releases from target cells are differential events in human monocyte/macrophage-mediated cytotoxicity.
Higashi N; Taki H; Nishimura Y; Higuchi M; Osawa T
Cell Immunol; 1993 Sep; 150(2):333-42. PubMed ID: 8370076
[TBL] [Abstract][Full Text] [Related]
30. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
Richter M; Banerjee D; Sklar S
Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
[TBL] [Abstract][Full Text] [Related]
31. Surface membrane heterogeneity among human mononuclear phagocytes.
Biondi A; Rossing TH; Bennett J; Todd RF
J Immunol; 1984 Mar; 132(3):1237-43. PubMed ID: 6198386
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of macrophage and monocyte cytotoxicity by the surface active material of lung lining fluid.
Baughman RP; Mangels DJ; Strohofer S; Corser BC
J Lab Clin Med; 1987 Jun; 109(6):692-7. PubMed ID: 3585142
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas.
Allavena P; Introna M; Mangioni C; Mantovani A
J Natl Cancer Inst; 1981 Aug; 67(2):319-25. PubMed ID: 6943371
[TBL] [Abstract][Full Text] [Related]
34. Activating factors for nonspecific and antibody-dependent cytotoxicity by human and murine mononuclear phagocytes.
Ralph P
Lymphokine Res; 1984; 3(4):153-61. PubMed ID: 6208440
[No Abstract] [Full Text] [Related]
35. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
[TBL] [Abstract][Full Text] [Related]
36. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
Schorlemmer HU; Bosslet K; Sedlacek HH
Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
[TBL] [Abstract][Full Text] [Related]
37. Killing of Listeria monocytogenes by human neutrophils and monocytes, but not by monocyte-derived macrophages.
Czuprynski CJ; Campbell PA; Henson PM
J Reticuloendothel Soc; 1983 Jul; 34(1):29-44. PubMed ID: 6410063
[TBL] [Abstract][Full Text] [Related]
38. Characterization of human breast milk macrophages cytostatic for human cell lines.
Balkwill FR; Hogg N
J Immunol; 1979 Oct; 123(4):1451-6. PubMed ID: 573301
[TBL] [Abstract][Full Text] [Related]
39. Species restriction in cytostatic activity of human and murine monocytes and macrophages.
Hogg N; Balkwill FR
Immunology; 1981 May; 43(1):197-204. PubMed ID: 7251049
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic effector cell function at different stages of human monocyte-macrophage maturation.
Andreesen R; Osterholz J; Bross KJ; Schulz A; Luckenbach GA; Löhr GW
Cancer Res; 1983 Dec; 43(12 Pt 1):5931-6. PubMed ID: 6357433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
